In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others
Systemic effects show more variability
Professional Support: Provides pre-sales consultation, COA, test spectra, and after-sales support
The decision framework: if your all-in cost with insurance (including time spent on prior auth and appeals) exceeds your cost with compounded medication, and you're comfortable with compounded medication's regulatory status, the compounded route is rational